Literature DB >> 28591115

Alternative drug sensitivity metrics improve preclinical cancer pharmacogenomics.

Marc Hafner1, Mario Niepel1, Peter K Sorger1.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28591115      PMCID: PMC5668135          DOI: 10.1038/nbt.3882

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  18 in total

1.  Cell Death and Cancer Therapy: Don't Forget to Kill the Cancer Cell!

Authors:  Anthony Letai
Journal:  Clin Cancer Res       Date:  2015-11-15       Impact factor: 12.531

2.  Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.

Authors:  R I Fisher; E R Gaynor; S Dahlberg; M M Oken; T M Grogan; E M Mize; J H Glick; C A Coltman; T P Miller
Journal:  N Engl J Med       Date:  1993-04-08       Impact factor: 91.245

3.  Measuring Cancer Drug Sensitivity and Resistance in Cultured Cells.

Authors:  Mario Niepel; Marc Hafner; Mirra Chung; Peter K Sorger
Journal:  Curr Protoc Chem Biol       Date:  2017-06-19

4.  Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737.

Authors:  Samantha R Oakes; François Vaillant; Elgene Lim; Lily Lee; Kelsey Breslin; Frank Feleppa; Siddhartha Deb; Matthew E Ritchie; Elena Takano; Teresa Ward; Stephen B Fox; Daniele Generali; Gordon K Smyth; Andreas Strasser; David C S Huang; Jane E Visvader; Geoffrey J Lindeman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-18       Impact factor: 11.205

5.  Inconsistency in large pharmacogenomic studies.

Authors:  Benjamin Haibe-Kains; Nehme El-Hachem; Nicolai Juul Birkbak; Andrew C Jin; Andrew H Beck; Hugo J W L Aerts; John Quackenbush
Journal:  Nature       Date:  2013-11-27       Impact factor: 49.962

6.  Phosphatidylinositol 3-kinase hyperactivation results in lapatinib resistance that is reversed by the mTOR/phosphatidylinositol 3-kinase inhibitor NVP-BEZ235.

Authors:  Pieter J A Eichhorn; Magüi Gili; Maurizio Scaltriti; Violeta Serra; Marta Guzman; Wouter Nijkamp; Roderick L Beijersbergen; Vanesa Valero; Joan Seoane; René Bernards; José Baselga
Journal:  Cancer Res       Date:  2008-11-15       Impact factor: 12.701

7.  Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset.

Authors:  Brinton Seashore-Ludlow; Matthew G Rees; Jaime H Cheah; Murat Cokol; Edmund V Price; Matthew E Coletti; Victor Jones; Nicole E Bodycombe; Christian K Soule; Joshua Gould; Benjamin Alexander; Ava Li; Philip Montgomery; Mathias J Wawer; Nurdan Kuru; Joanne D Kotz; C Suk-Yee Hon; Benito Munoz; Ted Liefeld; Vlado Dančík; Joshua A Bittker; Michelle Palmer; James E Bradner; Alykhan F Shamji; Paul A Clemons; Stuart L Schreiber
Journal:  Cancer Discov       Date:  2015-10-19       Impact factor: 39.397

8.  Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials.

Authors:  J I Johnson; S Decker; D Zaharevitz; L V Rubinstein; J M Venditti; S Schepartz; S Kalyandrug; M Christian; S Arbuck; M Hollingshead; E A Sausville
Journal:  Br J Cancer       Date:  2001-05-18       Impact factor: 7.640

9.  Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs.

Authors:  Marc Hafner; Mario Niepel; Mirra Chung; Peter K Sorger
Journal:  Nat Methods       Date:  2016-05-02       Impact factor: 28.547

10.  An unbiased metric of antiproliferative drug effect in vitro.

Authors:  Leonard A Harris; Peter L Frick; Shawn P Garbett; Keisha N Hardeman; B Bishal Paudel; Carlos F Lopez; Vito Quaranta; Darren R Tyson
Journal:  Nat Methods       Date:  2016-05-02       Impact factor: 28.547

View more
  23 in total

1.  Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.

Authors:  Marc Hafner; Caitlin E Mills; Kartik Subramanian; Chen Chen; Mirra Chung; Sarah A Boswell; Robert A Everley; Changchang Liu; Charlotte S Walmsley; Dejan Juric; Peter K Sorger
Journal:  Cell Chem Biol       Date:  2019-06-06       Impact factor: 8.116

2.  Increased 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 activity in response to EGFR signaling contributes to non-small cell lung cancer cell survival.

Authors:  Nadiia Lypova; Sucheta Telang; Jason Chesney; Yoannis Imbert-Fernandez
Journal:  J Biol Chem       Date:  2019-05-24       Impact factor: 5.157

3.  Improved Dose-Response Relationship of (+)-Discodermolide-Taxol Hybrid Congeners.

Authors:  Celine Nadaradjane; Chia-Ping Huang Yang; Alicia Rodriguez-Gabin; Kenny Ye; Keizo Sugasawa; Onur Atasoylu; Amos B Smith; Susan Band Horwitz; Hayley M McDaid
Journal:  J Nat Prod       Date:  2018-03-09       Impact factor: 4.050

4.  Chemistry-First Approach for Nomination of Personalized Treatment in Lung Cancer.

Authors:  Elizabeth A McMillan; Myung-Jeom Ryu; Caroline H Diep; Saurabh Mendiratta; Jean R Clemenceau; Rachel M Vaden; Ju-Hwa Kim; Takashi Motoyaji; Kyle R Covington; Michael Peyton; Kenneth Huffman; Xiaofeng Wu; Luc Girard; Yeojin Sung; Pei-Hsaun Chen; Prema L Mallipeddi; Joo Young Lee; Jordan Hanson; Sukesh Voruganti; Yunku Yu; Sunho Park; Jessica Sudderth; Christopher DeSevo; Donna M Muzny; HarshaVardhan Doddapaneni; Adi Gazdar; Richard A Gibbs; Tae-Hyun Hwang; John V Heymach; Ignacio Wistuba; Kevin R Coombes; Noelle S Williams; David A Wheeler; John B MacMillan; Ralph J Deberardinis; Michael G Roth; Bruce A Posner; John D Minna; Hyun Seok Kim; Michael A White
Journal:  Cell       Date:  2018-04-19       Impact factor: 41.582

5.  Integration of Tumor Genomic Data with Cell Lines Using Multi-dimensional Network Modules Improves Cancer Pharmacogenomics.

Authors:  James T Webber; Swati Kaushik; Sourav Bandyopadhyay
Journal:  Cell Syst       Date:  2018-11-07       Impact factor: 10.304

6.  A multitargeted probe-based strategy to identify signaling vulnerabilities in cancers.

Authors:  Suman Rao; Guangyan Du; Marc Hafner; Kartik Subramanian; Peter K Sorger; Nathanael S Gray
Journal:  J Biol Chem       Date:  2019-03-11       Impact factor: 5.157

Review 7.  The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations.

Authors:  Alexandra B Keenan; Sherry L Jenkins; Kathleen M Jagodnik; Simon Koplev; Edward He; Denis Torre; Zichen Wang; Anders B Dohlman; Moshe C Silverstein; Alexander Lachmann; Maxim V Kuleshov; Avi Ma'ayan; Vasileios Stathias; Raymond Terryn; Daniel Cooper; Michele Forlin; Amar Koleti; Dusica Vidovic; Caty Chung; Stephan C Schürer; Jouzas Vasiliauskas; Marcin Pilarczyk; Behrouz Shamsaei; Mehdi Fazel; Yan Ren; Wen Niu; Nicholas A Clark; Shana White; Naim Mahi; Lixia Zhang; Michal Kouril; John F Reichard; Siva Sivaganesan; Mario Medvedovic; Jaroslaw Meller; Rick J Koch; Marc R Birtwistle; Ravi Iyengar; Eric A Sobie; Evren U Azeloglu; Julia Kaye; Jeannette Osterloh; Kelly Haston; Jaslin Kalra; Steve Finkbiener; Jonathan Li; Pamela Milani; Miriam Adam; Renan Escalante-Chong; Karen Sachs; Alex Lenail; Divya Ramamoorthy; Ernest Fraenkel; Gavin Daigle; Uzma Hussain; Alyssa Coye; Jeffrey Rothstein; Dhruv Sareen; Loren Ornelas; Maria Banuelos; Berhan Mandefro; Ritchie Ho; Clive N Svendsen; Ryan G Lim; Jennifer Stocksdale; Malcolm S Casale; Terri G Thompson; Jie Wu; Leslie M Thompson; Victoria Dardov; Vidya Venkatraman; Andrea Matlock; Jennifer E Van Eyk; Jacob D Jaffe; Malvina Papanastasiou; Aravind Subramanian; Todd R Golub; Sean D Erickson; Mohammad Fallahi-Sichani; Marc Hafner; Nathanael S Gray; Jia-Ren Lin; Caitlin E Mills; Jeremy L Muhlich; Mario Niepel; Caroline E Shamu; Elizabeth H Williams; David Wrobel; Peter K Sorger; Laura M Heiser; Joe W Gray; James E Korkola; Gordon B Mills; Mark LaBarge; Heidi S Feiler; Mark A Dane; Elmar Bucher; Michel Nederlof; Damir Sudar; Sean Gross; David F Kilburn; Rebecca Smith; Kaylyn Devlin; Ron Margolis; Leslie Derr; Albert Lee; Ajay Pillai
Journal:  Cell Syst       Date:  2017-11-29       Impact factor: 10.304

Review 8.  Nuisance compounds in cellular assays.

Authors:  Jayme L Dahlin; Douglas S Auld; Ina Rothenaigner; Steve Haney; Jonathan Z Sexton; J Willem M Nissink; Jarrod Walsh; Jonathan A Lee; John M Strelow; Francis S Willard; Lori Ferrins; Jonathan B Baell; Michael A Walters; Bruce K Hua; Kamyar Hadian; Bridget K Wagner
Journal:  Cell Chem Biol       Date:  2021-02-15       Impact factor: 8.116

9.  Thunor: visualization and analysis of high-throughput dose-response datasets.

Authors:  Alexander L R Lubbock; Leonard A Harris; Vito Quaranta; Darren R Tyson; Carlos F Lopez
Journal:  Nucleic Acids Res       Date:  2021-07-02       Impact factor: 16.971

Review 10.  Differentiable biology: using deep learning for biophysics-based and data-driven modeling of molecular mechanisms.

Authors:  Mohammed AlQuraishi; Peter K Sorger
Journal:  Nat Methods       Date:  2021-10-04       Impact factor: 28.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.